ACCOZOLE letrozole 2.5 mg film-coated tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Nopērc to tagad

Aktīvā sastāvdaļa:

letrozole, Quantity: 2.5 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Letrozole

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; sodium starch glycollate type A; maize starch; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400

Ievadīšanas:

Oral

Vienības iepakojumā:

30 tablets

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Indicated for the treatment of post menopausal women with hormone receptor positive breast cancer. The safety and efficacy of neoadjuvant use of Letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Produktu pārskats:

Visual Identification: Yellow, round, biconvex, film-coated tablet plain on both sides.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2013-07-19